Attached files
| file | filename |
|---|---|
| S-1/A - ENDV S-1/A1 04/24/15 - ENDONOVO THERAPEUTICS, INC. | endvs1a1_042415apg.htm |
| EX-5.1 - EXHIBIT 5.1 - ENDONOVO THERAPEUTICS, INC. | ex5_1apg.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Amendment Number 1 to Form S-1 of our report dated April 2, 2015, with respect to the consolidated financial statements of Endonovo Therapeutics, Inc. and Subsidiaries appearing in the Company’s Annual Report on Form 10-K for the years ended December 31, 2014 and 2013. Our report relating to the consolidated financial statements for the years ended December 31, 2014 and 2013 contains an explanatory paragraph regarding the Company’s ability to continue as a going concern. We also consent to the reference of our Firm under the caption “Experts” in the Registration Statement.
Rose, Snyder & Jacobs LLP
Encino, California
April 22, 2015